NOTCH mutations leading to increased receptor signaling

Details for Australian Patent Application No. 2005267724 (hide)

Owner The Brigham and Women's Hospital, Inc. Dana-Farber Cancer Institute Inc.

Inventors Weng, Andrew P.; Ferrando, Adolpho A.; Look, A. Thomas; Aster, Jon C.; Blacklow, Stephen C.

Agent Spruson & Ferguson

Pub. Number AU-B-2005267724

PCT Pub. Number WO2006/015375

Priority 60/598,546 04.08.04 US; 60/672,053 18.04.05 US

Filing date 4 August 2005

Wipo publication date 9 February 2006

Acceptance publication date 30 October 2008

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/00 (2006.01) Mutation or genetic engineering

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015375 Priority application(s): WO2006/015375

30 October 2008 Application Accepted

  Published as AU-B-2005267724

26 February 2009 Standard Patent Sealed

3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267725-Monocot AHASS sequences and methods of use

2005267722-Antibodies to Dkk-1